581 related articles for article (PubMed ID: 8770357)
1. Hormonal male contraception: progress and prospects for the 21st century.
Handelsman DJ
Aust N Z J Med; 1995 Dec; 25(6):808-16. PubMed ID: 8770357
[TBL] [Abstract][Full Text] [Related]
2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
3. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
4. Male contraception.
Wu FC
Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):1-23. PubMed ID: 8736719
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
6. Developments in the control of testicular function.
Swerdloff RS; Wang C; Bhasin S
Baillieres Clin Endocrinol Metab; 1992 Apr; 6(2):451-83. PubMed ID: 1377467
[TBL] [Abstract][Full Text] [Related]
7. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Guerin JF; Rollet J
Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
[TBL] [Abstract][Full Text] [Related]
9. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
10. The use of testosterone as a male contraceptive.
Amory JK; Bremner WJ
Baillieres Clin Endocrinol Metab; 1998 Oct; 12(3):471-84. PubMed ID: 10332567
[TBL] [Abstract][Full Text] [Related]
11. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human spermatogenesis by testosterone implants.
Handelsman DJ; Conway AJ; Boylan LM
J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
[TBL] [Abstract][Full Text] [Related]
13. Male hormonal contraception. What prospects exist and how acceptable are they?
Griffin D; Ringheim K
Plan Parent Chall; 1996; (2):20-4. PubMed ID: 12291936
[TBL] [Abstract][Full Text] [Related]
14. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
15. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
16. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
Sukcharoen N; Aribarg A; Kriangsinyos R; Chanprasit Y; Ngeamvijawat J
J Med Assoc Thai; 1996 Dec; 79(12):767-73. PubMed ID: 9071080
[TBL] [Abstract][Full Text] [Related]
17. Looking for the "male pill".
Herndon N
Netw Res Triangle Park N C; 1992 Aug; 13(1):20-3. PubMed ID: 12317724
[TBL] [Abstract][Full Text] [Related]
18. Bridging the gender gap in contraception: another hurdle cleared.
Handelsman DJ
Med J Aust; 1991 Feb; 154(4):230-3. PubMed ID: 1994193
[TBL] [Abstract][Full Text] [Related]
19. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
20. Male fertility regulation: the challenges for the year 2000.
Waites GM
Br Med Bull; 1993 Jan; 49(1):210-21. PubMed ID: 8324610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
